0000000000640490

AUTHOR

G. Imbriaco

showing 2 related works from this author

Cost-effectiveness of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma

2009

Oncologymedicine.medical_specialtyCost effectivenessComputed tomographyInternal medicineBiopsymedicinebiopsynon-invasive diagnosiAASLDHepatologymedicine.diagnostic_testRecallbusiness.industryNon invasiveGastroenterologycomputed tomographymedicine.diseaseAmerican Association for the Study of the Liver Diseasegadolinium-magnetic resonance imagingsmall hepatocellular carcinomaCost-effectiveneHepatocellular carcinomaRadiologybusinesscontrast-enhanced ultrasoundContrast-enhanced ultrasoundDigestive and Liver Disease
researchProduct

Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma.

2010

Abstract Background Which is the least expensive recall policy for nodules in the cirrhotic liver remains unclear. Aim Aim of the study was to analyze the costs of different recall diagnostic strategies of hepatocellular carcinoma (HCC) on cirrhosis on a real series of patients. Methods 75 consecutive small liver nodules (10–30 mm) detected at conventional ultrasonography in 60 patients with cirrhosis were submitted to contrast-enhanced ultrasound, computed tomography and gadolinium-magnetic resonance imaging with a final diagnosis established according to the latest guidelines which include different strategies for nodules 10–19 mm or ≥20 mm. The actual costs required to fully characterise…

AdultDiagnostic ImagingMalemedicine.medical_specialtyCirrhosisCarcinoma HepatocellularCost effectivenessHCC diagnosismedicineHumansProspective StudiesAgedAged 80 and overHepatologyRecallbusiness.industryNon invasiveUltrasoundLiver NeoplasmsGastroenterologyNodule (medicine)Middle Agedmedicine.diseaseHepatocellular carcinomaCost analysisCosts and Cost AnalysisFemaleRadiologymedicine.symptombusiness
researchProduct